SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-010475
Filing Date
2016-12-08
Accepted
2016-12-08 17:14:46
Documents
7
Period of Report
2016-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20161206x8k.htm 8-K 43056
2 EX-1.1 bpmc-20161206ex113b6f254.htm EX-1.1 301433
3 EX-5.1 bpmc-20161206ex5148a1949.htm EX-5.1 10714
4 EX-99.1 bpmc-20161206ex991932b34.htm EX-99.1 13308
5 EX-99.2 bpmc-20161206ex9925ef176.htm EX-99.2 12547
6 GRAPHIC bpmc20161206ex991932b34001.jpg GRAPHIC 1060978
7 GRAPHIC bpmc20161206ex9925ef176001.jpg GRAPHIC 1060978
  Complete submission text file 0001558370-16-010475.txt   3202509
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 162042179
SIC: 2834 Pharmaceutical Preparations